BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 7, 1999, Pages 729-739

  Ferrer, Isidro ^a,b   Marín, Conxita ^b   Rey, Ma Jesús ^b   Ribalta, Teresa ^b   Goutan, Esther ^b   Blanco, Rosa ^b   Tolosa, Eduard ^b   Martí, Eulalia ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Alzheimer disease; BDNF; Full length TrkB; Truncated TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ISOPROTEIN; PEPTIDE FRAGMENT; PROTEIN TYROSINE KINASE;

AGED; ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CADAVER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLIA CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NERVE CELL DEGENERATION; NEURITE; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SENILE PLAQUE;

EID: 0032805204     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199907000-00007     Document Type: Article

References (58)

1. Leibrock J, Lottspeich F, Hohn A, et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989;341: 149-52
2. Ernfors P, Ibañez CF, Ebendal T, Olson L, Person H. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: Developmental and topographical expression in the brain. Proc Natl Acad Sci USA 1990;87:5454-58
3. Barbacid M. Structural and functional properties of the Trk family of neurotrophin receptors. Ann NY Acad Sci 1995;766:442-58
4. Klein R, Conway D, Parada LF, Barbacid M. The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell 1990;61:647-56
5. Middlemas DS, Lindberg RA, Hunter T. TrkB, a neural receptor protein-tyrosine kinase: Evidence for a full-length and two truncated receptors. Mol Cell Biol 1991;11:143-53
6. Baxter GT, Radeke MJ, Kuo RC, et al. Signal transduction mediated by the truncated trkB receptor isoforms, trkB, T1 and trkB, T2. J Neurosci 1999;17:2683-90
7. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289-317
8. Yang K, Pérez-Polo JR, Mu XS, et al. Increased expression of brain-derived neurotrophic factor but not neurotrophin-3 mRNA in rat brain after cortical brain injury. J Neurosci Res 1996;44:157-64
9. Hicks RR, Numan S, Dhillon HS, Prasad MR, Seroogy KB. Alterations in BDNF and NT-3 mRNAs in rat hippocampus after experimental brain trauma. Mol Brain Res 1997;48:401-6
10. Piehl F, Frisen J, Risling M, Hokfelt T, Cullheim S. Increased trkB mRNA expression by axotomized motoneurons. NeuroReport 1994;5:697-700
11. Kobayashi NR, Bedard AM, Hincke MT, Tetzlaff W. Increased expression of BDNF and trkB mRNA in rat facial motoneurons after axotomy. Eur J Neurosci 1996;8:1018-29
12. Gwag BJ, Sessler F, Kimmerer K, Springer JE. Neurotrophic factor mRNA expression in dentate gyrus is increased following angular bundle transection. Brain Res 1994;647:23-29
13. Lindwall O, Ernfors P, Bengzon J, et al. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 in the adult brain following cerebral ischemia. Proc Ntal Acad Sci USA 1992;89:648-52
14. Takeda A, Onodera H, Sugimoto K, et al. Coordinated expression of messenger mRNAs for nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the rat hippocampus following transient forebrain ischemia. Neuroscience 1993;55:23-31
15. Kokaia Z, Nawa H, Uchino H, et al. Regional brain-derived neurotrophic factor and protein levels following transient forebrain ischemia in the rat. Mol Brain Res 1996;38:139-44
16. Arai S, Kinouchi H, Akabane A, et al. Induction of brain-derived neurotrophic factor (BDNF) and the receptor trkB mRNA following middle cerebral artery occlusion in rat. Neurosci Lett 1996;211: 57-60
17. Dugich-Djordjevic MM, Tocco G, Lapchak PA, et al. Regionally specific and rapid increases in brain-derived neurotrophic factor messenger RNA in the adult rat brain following seizures induced by systemic administration of kainic acid. Neuroscience 1992;47: 303-15
18. Dugich-Djordjevic MM, Ohsawa F, Okazaki T, et al. Differential regulation of catalytic and non-catalytic trkB messenger RNAs in the rat hippocampus following seizures induced by systemic administration of kainate. Neuroscience 1995;66:861-77
19. Goutan E, Martí E, Ferrer I. BDNF, and full-length and truncated TrkB expression in the hippocampus of the rat following kainic acid excitotoxic damage. Evidence of complex time-dependent and cell-specific responses. Mol Brain Res 1998;59:154-64
20. Phillips HS, Hains JM, Armanini M, et al. JW. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 1991;7:695-702
21. Murray KD, Gall CM, Jones EG, Isackson PJ. Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease. Neuroscience 1994;60:37-48
22. Connor B, Young D, Yan Q, et al. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Mol Brain Res 1997;49:71-81
23. Narisawa-Saito M, Wakabayashi K, Tsuji S, Takahashi H, Nawa H. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. NeuroReport 1996;7:2925-28
24. Boissière F, Faucheux B, Agid Y, Hirsch EC. Expression of catalytic trkB gene in the striatum and basal forebrain of patients with Alzheimer's disease: An in situ hybridization study. Neurosci Lett 1997;221:141-44
25. Salehi A, Verhaagen J, Dijkhuizen PA, Swaab DF. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 1996;75:373-87
26. Connor B, Young D, Lawlor P, et al. Trk receptor alterations in Alzheimer's disease. Mol Brain Res 1996;42:1-17
27. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
28. Kokaia Z, Bengzon J, Metsis M, et al. Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc Natl Acad Sci USA 1993;90:6711-15
29. Zhou XF, Parada LF, Soppet D, Rush RA. Distribution of TrkB tyrosine kinase immunoreactivity in the rat central nervous system. Brain Res 1993;622:63-70
30. Moretto G, Xu RY, Walker DG, Kim SU. Co-expression of mRNA for neurotrophic factors in human neurons and glial cells in culture. J Neuropathol Exp Neurol 1994;53:78-85
31. Inoue S, Susukida M, Ikeda K, Murase K, Hayashi K. Dopaminergic transmitter up-regulation of brain-deived neurotrophic factor (BDNF) and nerve growth factor (NGF) synthesis in mouse astrocytes in culture. Biochem Biophys Res Commun 1997;238:468-72
32. Pan JB, Monteggia LM, Giordano T. Altered levels and splicing of the amyloid precursor protein in the adult rat hippocampus after treatment with DMSO or retinoic acid. Mol Brain Res 1993;18: 259-66
33. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 1995;18:223-53
34. Biffo S, Offenhauser N, Carter BD, Barde YA. Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development. Development 1995;121:2461-70
35. Eide FF, Vining BL, Eide BL, et al. Naturally-occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci 1996;16:3123-29
36. Fryer RH, Kaplan DR, Kromer LF. Truncated TrkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro. Exp Neurol 1997;148:616-27
37. Jette N, Cole MS, Fahnestock M. NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients. Mol Brain Res 1994;25:242-50
38. Fahnestock M, Scott SA, Jette N, Weingartner JA, Crutcher KA. Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. Mol Brain Res 1996;42:175-78
39. Scott SA, Crutcher KA. Nerve growth factor and Alzheimer's disease. Rev Neurosci 1994;5:179-211
40. Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J. Detection of NGF-like activity in human brain tissue: Increased levels in Alzheimer's disease. J Neurosci 1993;13:2540-50
41. Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 1995;15:6213-21
42. Boissière F, Lehericy S, Strada O, Agid Y, Hirsch EC. Neurotrophin receptors and selective loss of cholinergic neurons in Alzheimer's disease. Mol Chem Neuropathol 1996;28:219-23
43. Mufson EJ, Lavine N, Jaffar S, et al. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 1997;146:91-103
44. Hock C, Heese K, Muller-Spahn F, et al. Decreased TrkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci Lett 1998;241:151-54
45. Aguado F, Ballabriga J, Pozas E, Ferrer I. TrkA immunoreactivity in reactive astrocytes in human neurodegenerative diseases and colchicine-treated rats. Acta Neuropathol 1998;96:495-501
46. Treanor JJ, Dawbarn D, Allen SJ, MacGowan SH, Wilcock GK. Low affinity nerve growth factor receptor binding in normal and Alzheimer's disease basal forebrain. Neurosci Lett 1991;121:73-76
47. Kerwin JM, Morris CM, Perry RH, Perry EK. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's diseases. Neurosci Lett 1992;143:101-4
48. Knüsel B, Beck KD, Winslow JW, et al. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 1992;12:4391-4402
49. Morse JK, Wiegand SJ, Anderson K, et al. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J Neurosci 1993;13:4146-56
50. Beck T, Lindholm D, Castrén E, Wree A. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J Cereb Blood Flow Metab 1994;14:689-92
51. Tsukuhara T, Yonekawa Y, Tanaka F, et al. The role of brain-derived neurotrophic factor in transient forebrain ischemia in the rat brain. Neurosurgery 1994;34:323-31
52. Ferrer I, Ballabriga J, Martí E, et al. BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia. Brain Pathol 1998;8:253-61
53. Schuman EM. Neurotrophin regulation of synaptic transmission. Curr Op Neurobiol 1999;9:105-9
54. Ko JY, Gwag BJ, Lobner D, Choi DW. Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 1995;268: 573-75
55. Rudge JS, Mather PE, Pasnikowski EM, et al. Endogenous BDNF protein is increased in adult rat hippocampus after kainic acid-induced excitotoxic insult but exogenous BDNF is not neuroprotective. Exp Neurol 1998;149:398-410
56. Frank L, Ventimiglia R, Anderson K, Lindsay RM, Rudge JS. BDNF down-regulates neurotrophin responsiveness, TrkB protein and trkB mRNA levels in cultured rat hippocampal neurons. Eur J Neurosci 1996;8:1220-30
57. Knüsel B, Gao H, Okazaki T, et al. Ligand-induced down-regulation of trkB messenger, protein and tyrosine phosphorylation in rat cortical neurons. Neuroscience 1997;78:851-62
58. Carter BD, Zirrgiebeld U, Barde YA. Differential regulation of p21 ras activation in neurons by nerve growth factor and brain-derived growth factor. J Biol Chem 1995;270:21751-57